These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1502 related articles for article (PubMed ID: 15350163)

  • 1. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease.
    Keating GM
    Drugs; 2012 Jan; 72(2):273-300. PubMed ID: 22217233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.
    ZuWallack AR; ZuWallack RL
    Expert Opin Pharmacother; 2004 Aug; 5(8):1827-35. PubMed ID: 15264997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formoterol: a review of its use in chronic obstructive pulmonary disease.
    Cheer SM; Scott LJ
    Am J Respir Med; 2002; 1(4):285-300. PubMed ID: 14720051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.
    Donohue JF; van Noord JA; Bateman ED; Langley SJ; Lee A; Witek TJ; Kesten S; Towse L
    Chest; 2002 Jul; 122(1):47-55. PubMed ID: 12114338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease.
    van Noord JA; Smeets JJ; Custers FL; Korducki L; Cornelissen PJ
    Eur Respir J; 2002 Apr; 19(4):639-44. PubMed ID: 11998992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.
    Brusasco V; Hodder R; Miravitlles M; Korducki L; Towse L; Kesten S
    Thorax; 2003 May; 58(5):399-404. PubMed ID: 12728159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group.
    van Noord JA; Bantje TA; Eland ME; Korducki L; Cornelissen PJ
    Thorax; 2000 Apr; 55(4):289-94. PubMed ID: 10722768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of aclidinium bromide 400 μg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD.
    Fuhr R; Magnussen H; Sarem K; Llovera AR; Kirsten AM; Falqués M; Caracta CF; Garcia Gil E
    Chest; 2012 Mar; 141(3):745-752. PubMed ID: 21903737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients.
    Beier J; van Noord J; Deans A; Brooks J; Maden C; Baggen S; Mehta R; Cahn A
    Int J Chron Obstruct Pulmon Dis; 2012; 7():153-64. PubMed ID: 22419863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.
    Hanania NA; Boota A; Kerwin E; Tomlinson L; Denis-Mize K
    Drugs; 2009 Jun; 69(9):1205-16. PubMed ID: 19537837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease.
    Littner MR; Ilowite JS; Tashkin DP; Friedman M; Serby CW; Menjoge SS; Witek TJ
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1136-42. PubMed ID: 10764302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD.
    Hansel TT; Barnes PJ
    Drugs Today (Barc); 2002 Sep; 38(9):585-600. PubMed ID: 12582447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD.
    Rabe KF; Timmer W; Sagkriotis A; Viel K
    Chest; 2008 Aug; 134(2):255-262. PubMed ID: 18403672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group.
    Casaburi R; Briggs DD; Donohue JF; Serby CW; Menjoge SS; Witek TJ
    Chest; 2000 Nov; 118(5):1294-302. PubMed ID: 11083677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD.
    van Noord JA; Aumann JL; Janssens E; Verhaert J; Smeets JJ; Mueller A; Cornelissen PJ
    Chest; 2006 Mar; 129(3):509-17. PubMed ID: 16537846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes.
    Celli B; ZuWallack R; Wang S; Kesten S
    Chest; 2003 Nov; 124(5):1743-8. PubMed ID: 14605043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiotropium bromide.
    Hvizdos KM; Goa KL
    Drugs; 2002; 62(8):1195-203; discussion 1204-5. PubMed ID: 12010082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.